Document is current
Any future updates will be listed below
-
Authors
Rassy, Elie https://orcid.org/0000-0002-7906-0991
André, Fabrice https://orcid.org/0000-0001-5795-8357
- License Information
-
More Information
Article History
First Online: 11 September 2024
Competing interests
: E.R. has received honoraria from Eli Lilly, Novartis and Seagen; has received travel support from Gilead, Mundipharma, Novartis, Pfizer and Roche; and research funding from Gilead, Menarini and MSD. F.A. has acted as a consultant and/or adviser of AstraZeneca, Daiichi–Sankyo, Lilly, Novartis, Pfizer, Relay Tx and Roche; has received travel support from Astrazeneca, GlaxoSmithKline, Lilly, Novartis and Roche; and has received research funding from AstraZeneca, Daiichi, Eli Lilly, Novartis, Pfizer and Roche.
